Figure 2From: A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck Overall survival. Median: CRT: 20.2 months; ST: 40.2 months; Cox regression analysis p = 0.026Back to article page